Phase 2 Trial to Assess Keytruda Combination Therapy in Ovarian Cancer
News
A Phase 2 clinical trial will assess for the first time whether the combination of the immunotherapy drug Keytruda (pembrolizumab) with two other drugs that have already been approved for ... Read more